Masanobu Horie

Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan

Masashi Mizuno, Yasuhiko Ito, Akio Tanaka et al. · Clinical and Experimental Nephrology · 2011 · 97 citations

Medicine, Nephrology, Dialysis +6

Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients

Yasuhiko Ito, Masashi Mizuno, Yasuhíro Suzuki et al. · Journal of the American Society of Nephrology · 2013 · 91 citations · Full text

Medicine, Cardiology, Pharmacology +13

Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis

Masafumi Fukagawa, Hideki Hirakata, Tatsuo Kagimura et al. · JAMA · 2021 · 90 citations · Full text

Medicine, Nephrology, Pharmacotherapy +14

Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry

Masashi Mizuno, Yasuhiko Ito, Yasuhíro Suzuki et al. · Clinical and Experimental Nephrology · 2016 · 38 citations · Full text

Medicine, Nephrology, Surgery +17

Glutathionyl hemoglobin in uremic patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis

Fumio Takayama, Shuichi Tsutsui, Masanobu Horie et al. · Kidney International · 2001 · 37 citations · Full text

Medicine, Hematology, Nephrology +14